HOSPITAL BARCELONA SCIAS

logotipo SCIAS

The Hospital de Barcelona - SCIAS participated in the first phase IIa, multicentre studies to assess the safety and efficacy of bone regeneration of progenitor cells processed with the Aastrom Replicell bioreactor in atrophic pseudarthrosis.

Última actualización: 12/01/2018